nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—HTR7—umbilical artery—type 1 diabetes mellitus	0.0638	0.444	CbGeAlD
Eletriptan—Stomach ache—Ramipril—type 1 diabetes mellitus	0.0192	0.0403	CcSEcCtD
Eletriptan—Cerebrovascular disorder—Ramipril—type 1 diabetes mellitus	0.0182	0.0383	CcSEcCtD
Eletriptan—Peripheral vascular disorder—Ramipril—type 1 diabetes mellitus	0.0166	0.0349	CcSEcCtD
Eletriptan—HTR7—autonomic nervous system—type 1 diabetes mellitus	0.0157	0.109	CbGeAlD
Eletriptan—Psoriasis—Ramipril—type 1 diabetes mellitus	0.013	0.0272	CcSEcCtD
Eletriptan—Parosmia—Ramipril—type 1 diabetes mellitus	0.0126	0.0264	CcSEcCtD
Eletriptan—Burning sensation—Ramipril—type 1 diabetes mellitus	0.0117	0.0246	CcSEcCtD
Eletriptan—HTR7—peripheral nervous system—type 1 diabetes mellitus	0.0113	0.0787	CbGeAlD
Eletriptan—Myocardial ischaemia—Ramipril—type 1 diabetes mellitus	0.0101	0.0213	CcSEcCtD
Eletriptan—Cough increased—Ramipril—type 1 diabetes mellitus	0.00891	0.0187	CcSEcCtD
Eletriptan—Glossitis—Ramipril—type 1 diabetes mellitus	0.00885	0.0186	CcSEcCtD
Eletriptan—HTR7—nerve—type 1 diabetes mellitus	0.00883	0.0614	CbGeAlD
Eletriptan—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00792	0.0166	CcSEcCtD
Eletriptan—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00766	0.0161	CcSEcCtD
Eletriptan—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00741	0.0156	CcSEcCtD
Eletriptan—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00737	0.0155	CcSEcCtD
Eletriptan—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00684	0.0144	CcSEcCtD
Eletriptan—Polyuria—Ramipril—type 1 diabetes mellitus	0.00674	0.0142	CcSEcCtD
Eletriptan—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00662	0.0139	CcSEcCtD
Eletriptan—Amnesia—Ramipril—type 1 diabetes mellitus	0.0063	0.0132	CcSEcCtD
Eletriptan—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00627	0.0132	CcSEcCtD
Eletriptan—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00625	0.0131	CcSEcCtD
Eletriptan—Purpura—Ramipril—type 1 diabetes mellitus	0.00614	0.0129	CcSEcCtD
Eletriptan—Arthritis—Ramipril—type 1 diabetes mellitus	0.00609	0.0128	CcSEcCtD
Eletriptan—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00546	0.0115	CcSEcCtD
Eletriptan—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00541	0.0114	CcSEcCtD
Eletriptan—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00533	0.0112	CcSEcCtD
Eletriptan—Gastritis—Ramipril—type 1 diabetes mellitus	0.00524	0.011	CcSEcCtD
Eletriptan—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00512	0.0107	CcSEcCtD
Eletriptan—Asthma—Ramipril—type 1 diabetes mellitus	0.00512	0.0107	CcSEcCtD
Eletriptan—Influenza—Ramipril—type 1 diabetes mellitus	0.00512	0.0107	CcSEcCtD
Eletriptan—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00498	0.0105	CcSEcCtD
Eletriptan—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00492	0.0103	CcSEcCtD
Eletriptan—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.0049	0.0103	CcSEcCtD
Eletriptan—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00471	0.00989	CcSEcCtD
Eletriptan—Weight increased—Ramipril—type 1 diabetes mellitus	0.00466	0.00978	CcSEcCtD
Eletriptan—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.0045	0.00944	CcSEcCtD
Eletriptan—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00447	0.00939	CcSEcCtD
Eletriptan—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00447	0.00939	CcSEcCtD
Eletriptan—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00445	0.00934	CcSEcCtD
Eletriptan—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00443	0.00931	CcSEcCtD
Eletriptan—Sweating—Ramipril—type 1 diabetes mellitus	0.00437	0.00918	CcSEcCtD
Eletriptan—Epistaxis—Ramipril—type 1 diabetes mellitus	0.0043	0.00903	CcSEcCtD
Eletriptan—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00428	0.00899	CcSEcCtD
Eletriptan—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00403	0.00847	CcSEcCtD
Eletriptan—HTR1B—cardiovascular system—type 1 diabetes mellitus	0.00401	0.0279	CbGeAlD
Eletriptan—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00395	0.00829	CcSEcCtD
Eletriptan—HTR1D—cardiovascular system—type 1 diabetes mellitus	0.00388	0.027	CbGeAlD
Eletriptan—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00382	0.00802	CcSEcCtD
Eletriptan—HTR1D—kidney—type 1 diabetes mellitus	0.0038	0.0264	CbGeAlD
Eletriptan—Flushing—Ramipril—type 1 diabetes mellitus	0.0038	0.00798	CcSEcCtD
Eletriptan—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.0037	0.00777	CcSEcCtD
Eletriptan—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00366	0.00768	CcSEcCtD
Eletriptan—Alopecia—Ramipril—type 1 diabetes mellitus	0.00362	0.0076	CcSEcCtD
Eletriptan—HTR2B—cardiovascular system—type 1 diabetes mellitus	0.00361	0.0251	CbGeAlD
Eletriptan—Tension—Ramipril—type 1 diabetes mellitus	0.0035	0.00734	CcSEcCtD
Eletriptan—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00349	0.00733	CcSEcCtD
Eletriptan—Nervousness—Ramipril—type 1 diabetes mellitus	0.00346	0.00727	CcSEcCtD
Eletriptan—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00343	0.0072	CcSEcCtD
Eletriptan—Tremor—Ramipril—type 1 diabetes mellitus	0.00334	0.00701	CcSEcCtD
Eletriptan—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00331	0.00694	CcSEcCtD
Eletriptan—Agitation—Ramipril—type 1 diabetes mellitus	0.00328	0.00688	CcSEcCtD
Eletriptan—Angioedema—Ramipril—type 1 diabetes mellitus	0.00326	0.00684	CcSEcCtD
Eletriptan—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.00324	0.0225	CbGeAlD
Eletriptan—Malaise—Ramipril—type 1 diabetes mellitus	0.00321	0.00675	CcSEcCtD
Eletriptan—Vertigo—Ramipril—type 1 diabetes mellitus	0.0032	0.00672	CcSEcCtD
Eletriptan—Syncope—Ramipril—type 1 diabetes mellitus	0.0032	0.00671	CcSEcCtD
Eletriptan—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00319	0.0067	CcSEcCtD
Eletriptan—Palpitations—Ramipril—type 1 diabetes mellitus	0.00315	0.00661	CcSEcCtD
Eletriptan—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00313	0.00658	CcSEcCtD
Eletriptan—Cough—Ramipril—type 1 diabetes mellitus	0.00311	0.00653	CcSEcCtD
Eletriptan—HTR7—cardiovascular system—type 1 diabetes mellitus	0.00309	0.0215	CbGeAlD
Eletriptan—Convulsion—Ramipril—type 1 diabetes mellitus	0.00309	0.00649	CcSEcCtD
Eletriptan—Myalgia—Ramipril—type 1 diabetes mellitus	0.00303	0.00637	CcSEcCtD
Eletriptan—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00303	0.00637	CcSEcCtD
Eletriptan—HTR7—kidney—type 1 diabetes mellitus	0.00303	0.021	CbGeAlD
Eletriptan—Anxiety—Ramipril—type 1 diabetes mellitus	0.00302	0.00635	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00301	0.00633	CcSEcCtD
Eletriptan—Discomfort—Ramipril—type 1 diabetes mellitus	0.003	0.0063	CcSEcCtD
Eletriptan—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00297	0.00623	CcSEcCtD
Eletriptan—Confusional state—Ramipril—type 1 diabetes mellitus	0.00293	0.00616	CcSEcCtD
Eletriptan—Oedema—Ramipril—type 1 diabetes mellitus	0.00291	0.00611	CcSEcCtD
Eletriptan—Shock—Ramipril—type 1 diabetes mellitus	0.00286	0.00601	CcSEcCtD
Eletriptan—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00285	0.00599	CcSEcCtD
Eletriptan—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00284	0.00596	CcSEcCtD
Eletriptan—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00283	0.00593	CcSEcCtD
Eletriptan—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00281	0.00591	CcSEcCtD
Eletriptan—Anorexia—Ramipril—type 1 diabetes mellitus	0.00277	0.00582	CcSEcCtD
Eletriptan—Hypotension—Ramipril—type 1 diabetes mellitus	0.00272	0.00571	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00265	0.00557	CcSEcCtD
Eletriptan—Insomnia—Ramipril—type 1 diabetes mellitus	0.00263	0.00553	CcSEcCtD
Eletriptan—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00261	0.00549	CcSEcCtD
Eletriptan—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00259	0.00545	CcSEcCtD
Eletriptan—Somnolence—Ramipril—type 1 diabetes mellitus	0.00259	0.00543	CcSEcCtD
Eletriptan—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00256	0.00538	CcSEcCtD
Eletriptan—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00253	0.00531	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00251	0.00527	CcSEcCtD
Eletriptan—Fatigue—Ramipril—type 1 diabetes mellitus	0.00251	0.00527	CcSEcCtD
Eletriptan—Constipation—Ramipril—type 1 diabetes mellitus	0.00249	0.00522	CcSEcCtD
Eletriptan—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.0024	0.00503	CcSEcCtD
Eletriptan—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00238	0.005	CcSEcCtD
Eletriptan—Mesoridazine—CHRM2—type 1 diabetes mellitus	0.00236	0.57	CrCbGaD
Eletriptan—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.00234	0.0163	CbGeAlD
Eletriptan—Urticaria—Ramipril—type 1 diabetes mellitus	0.00231	0.00485	CcSEcCtD
Eletriptan—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.0023	0.00483	CcSEcCtD
Eletriptan—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.0023	0.00483	CcSEcCtD
Eletriptan—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00214	0.0045	CcSEcCtD
Eletriptan—PTGS1—cardiovascular system—type 1 diabetes mellitus	0.00214	0.0149	CbGeAlD
Eletriptan—PTGS1—kidney—type 1 diabetes mellitus	0.00209	0.0145	CbGeAlD
Eletriptan—Asthenia—Ramipril—type 1 diabetes mellitus	0.00209	0.00438	CcSEcCtD
Eletriptan—Pruritus—Ramipril—type 1 diabetes mellitus	0.00206	0.00432	CcSEcCtD
Eletriptan—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00199	0.00418	CcSEcCtD
Eletriptan—Dizziness—Ramipril—type 1 diabetes mellitus	0.00192	0.00404	CcSEcCtD
Eletriptan—Vomiting—Ramipril—type 1 diabetes mellitus	0.00185	0.00388	CcSEcCtD
Eletriptan—Rash—Ramipril—type 1 diabetes mellitus	0.00183	0.00385	CcSEcCtD
Eletriptan—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00183	0.00385	CcSEcCtD
Eletriptan—Headache—Ramipril—type 1 diabetes mellitus	0.00182	0.00383	CcSEcCtD
Eletriptan—Thioridazine—CHRM2—type 1 diabetes mellitus	0.00178	0.43	CrCbGaD
Eletriptan—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.00175	0.0122	CbGeAlD
Eletriptan—CYP3A4—kidney—type 1 diabetes mellitus	0.00175	0.0121	CbGeAlD
Eletriptan—Nausea—Ramipril—type 1 diabetes mellitus	0.00173	0.00363	CcSEcCtD
Eletriptan—CYP2D6—kidney—type 1 diabetes mellitus	0.00172	0.012	CbGeAlD
Eletriptan—ABCB1—retina—type 1 diabetes mellitus	0.00149	0.0104	CbGeAlD
Eletriptan—ABCB1—nephron tubule—type 1 diabetes mellitus	0.00141	0.00978	CbGeAlD
Eletriptan—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.00126	0.00879	CbGeAlD
Eletriptan—ABCB1—kidney—type 1 diabetes mellitus	0.00124	0.0086	CbGeAlD
Eletriptan—ABCB1—pancreas—type 1 diabetes mellitus	0.00123	0.00854	CbGeAlD
Eletriptan—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.00106	0.00739	CbGeAlD
Eletriptan—PTGS1—Metabolism—HBA1—type 1 diabetes mellitus	0.000123	0.000326	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000122	0.000326	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—APOC3—type 1 diabetes mellitus	0.000122	0.000324	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000122	0.000324	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000121	0.000322	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000121	0.000321	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.00012	0.000319	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GSTT1—type 1 diabetes mellitus	0.00012	0.000318	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000119	0.000318	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	0.000118	0.000315	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000118	0.000314	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000116	0.00031	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—HBA1—type 1 diabetes mellitus	0.000116	0.000309	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000115	0.000307	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—APOC3—type 1 diabetes mellitus	0.000115	0.000307	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000114	0.000304	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000114	0.000303	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GSTT1—type 1 diabetes mellitus	0.000113	0.000301	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000113	0.0003	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	0.000113	0.0003	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000111	0.000296	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000111	0.000296	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000111	0.000294	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.00011	0.000293	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.00011	0.000292	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00011	0.000292	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000108	0.000288	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000107	0.000285	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000107	0.000283	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000106	0.000282	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000105	0.000281	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000105	0.000281	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000104	0.000278	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000104	0.000277	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000104	0.000276	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	0.000104	0.000276	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000103	0.000275	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000103	0.000275	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000103	0.000274	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	0.000103	0.000273	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000102	0.000271	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000101	0.00027	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000101	0.000269	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000101	0.000269	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	9.96e-05	0.000265	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.8e-05	0.000261	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—INS—type 1 diabetes mellitus	9.72e-05	0.000259	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CD80—type 1 diabetes mellitus	9.71e-05	0.000258	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GCG—type 1 diabetes mellitus	9.53e-05	0.000254	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.52e-05	0.000253	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.49e-05	0.000253	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.47e-05	0.000252	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.43e-05	0.000251	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.41e-05	0.00025	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.4e-05	0.00025	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.37e-05	0.000249	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.36e-05	0.000249	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SST—type 1 diabetes mellitus	9.26e-05	0.000246	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	9.22e-05	0.000245	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	9.22e-05	0.000245	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.21e-05	0.000245	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—INS—type 1 diabetes mellitus	9.17e-05	0.000244	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.17e-05	0.000244	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CD86—type 1 diabetes mellitus	9.08e-05	0.000242	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CD86—type 1 diabetes mellitus	9.02e-05	0.00024	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GCG—type 1 diabetes mellitus	9.02e-05	0.00024	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	8.9e-05	0.000237	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.87e-05	0.000236	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CD86—type 1 diabetes mellitus	8.83e-05	0.000235	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.83e-05	0.000235	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	8.78e-05	0.000234	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.69e-05	0.000231	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	8.68e-05	0.000231	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.67e-05	0.000231	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.65e-05	0.00023	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.62e-05	0.000229	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.62e-05	0.000229	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.62e-05	0.000229	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.56e-05	0.000228	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.53e-05	0.000227	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.44e-05	0.000225	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.38e-05	0.000223	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	8.3e-05	0.000221	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CD86—type 1 diabetes mellitus	8.3e-05	0.000221	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GCG—type 1 diabetes mellitus	8.25e-05	0.00022	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.2e-05	0.000218	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.19e-05	0.000218	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	8.18e-05	0.000218	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.14e-05	0.000216	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	8.11e-05	0.000216	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CAT—type 1 diabetes mellitus	8.07e-05	0.000215	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.05e-05	0.000214	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.04e-05	0.000214	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCR5—type 1 diabetes mellitus	8e-05	0.000213	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.97e-05	0.000212	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	7.95e-05	0.000211	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.94e-05	0.000211	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	7.93e-05	0.000211	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.89e-05	0.00021	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.88e-05	0.00021	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.87e-05	0.00021	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.83e-05	0.000208	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.83e-05	0.000208	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	7.81e-05	0.000208	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.72e-05	0.000205	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	7.72e-05	0.000205	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	7.7e-05	0.000205	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.66e-05	0.000204	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CAT—type 1 diabetes mellitus	7.63e-05	0.000203	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	7.51e-05	0.0002	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.48e-05	0.000199	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.36e-05	0.000196	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	7.33e-05	0.000195	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.25e-05	0.000193	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.24e-05	0.000193	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL2—type 1 diabetes mellitus	7.23e-05	0.000192	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.2e-05	0.000192	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.19e-05	0.000191	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	7.07e-05	0.000188	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	7.02e-05	0.000187	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.01e-05	0.000187	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.99e-05	0.000186	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	6.91e-05	0.000184	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	6.9e-05	0.000184	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	6.9e-05	0.000184	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	6.86e-05	0.000182	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	6.85e-05	0.000182	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.83e-05	0.000182	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL2—type 1 diabetes mellitus	6.82e-05	0.000181	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.79e-05	0.000181	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	6.77e-05	0.00018	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	6.73e-05	0.000179	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CD86—type 1 diabetes mellitus	6.73e-05	0.000179	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CD80—type 1 diabetes mellitus	6.62e-05	0.000176	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CD80—type 1 diabetes mellitus	6.58e-05	0.000175	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	6.5e-05	0.000173	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	6.46e-05	0.000172	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	6.45e-05	0.000172	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CD80—type 1 diabetes mellitus	6.44e-05	0.000171	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.43e-05	0.000171	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	6.41e-05	0.00017	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.39e-05	0.00017	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	6.36e-05	0.000169	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	6.35e-05	0.000169	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	6.29e-05	0.000167	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—INS—type 1 diabetes mellitus	6.26e-05	0.000167	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—INS—type 1 diabetes mellitus	6.22e-05	0.000165	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—INS—type 1 diabetes mellitus	6.09e-05	0.000162	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.08e-05	0.000162	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.07e-05	0.000161	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.05e-05	0.000161	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CD80—type 1 diabetes mellitus	6.05e-05	0.000161	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.02e-05	0.00016	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.01e-05	0.00016	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.99e-05	0.000159	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.97e-05	0.000159	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.9e-05	0.000157	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.89e-05	0.000157	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.88e-05	0.000157	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.86e-05	0.000156	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.84e-05	0.000155	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.8e-05	0.000154	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.74e-05	0.000153	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—INS—type 1 diabetes mellitus	5.72e-05	0.000152	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.59e-05	0.000149	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.56e-05	0.000148	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.53e-05	0.000147	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.53e-05	0.000147	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.51e-05	0.000146	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	5.5e-05	0.000146	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.49e-05	0.000146	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.45e-05	0.000145	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.44e-05	0.000145	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	5.37e-05	0.000143	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—INS—type 1 diabetes mellitus	5.36e-05	0.000143	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	5.35e-05	0.000142	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.34e-05	0.000142	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.22e-05	0.000139	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.11e-05	0.000136	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—INS—type 1 diabetes mellitus	5.07e-05	0.000135	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	5.06e-05	0.000135	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.02e-05	0.000133	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	5.01e-05	0.000133	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	4.91e-05	0.000131	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.91e-05	0.000131	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	4.7e-05	0.000125	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.66e-05	0.000124	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	4.65e-05	0.000124	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL2—type 1 diabetes mellitus	4.65e-05	0.000124	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ALB—type 1 diabetes mellitus	4.64e-05	0.000124	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	4.64e-05	0.000123	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.63e-05	0.000123	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.63e-05	0.000123	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL2—type 1 diabetes mellitus	4.62e-05	0.000123	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.6e-05	0.000122	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	4.54e-05	0.000121	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.53e-05	0.000121	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL2—type 1 diabetes mellitus	4.53e-05	0.00012	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	4.52e-05	0.00012	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.5e-05	0.00012	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.49e-05	0.000119	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.46e-05	0.000119	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—NOS3—type 1 diabetes mellitus	4.44e-05	0.000118	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	4.28e-05	0.000114	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.26e-05	0.000113	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL2—type 1 diabetes mellitus	4.25e-05	0.000113	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	4.25e-05	0.000113	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL6—type 1 diabetes mellitus	4.25e-05	0.000113	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	4.24e-05	0.000113	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.23e-05	0.000113	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	4.22e-05	0.000112	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	4.15e-05	0.00011	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.14e-05	0.00011	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.07e-05	0.000108	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL6—type 1 diabetes mellitus	4.01e-05	0.000107	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.92e-05	0.000104	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.89e-05	0.000104	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.81e-05	0.000101	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.58e-05	9.52e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.56e-05	9.47e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.54e-05	9.41e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.46e-05	9.21e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.45e-05	9.19e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.45e-05	9.18e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.43e-05	9.13e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.31e-05	8.8e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.25e-05	8.65e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	3.09e-05	8.22e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.01e-05	8.02e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.9e-05	7.72e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	2.84e-05	7.56e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	2.83e-05	7.54e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	2.82e-05	7.49e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	2.8e-05	7.45e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	2.76e-05	7.36e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6—type 1 diabetes mellitus	2.74e-05	7.28e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6—type 1 diabetes mellitus	2.72e-05	7.23e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	2.71e-05	7.21e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.66e-05	7.08e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	2.64e-05	7.04e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.64e-05	7.02e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	2.6e-05	6.93e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	2.58e-05	6.87e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.5e-05	6.65e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.49e-05	6.63e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	2.47e-05	6.57e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.03e-05	5.39e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.86e-05	4.94e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.7e-05	4.53e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.63e-05	4.33e-05	CbGpPWpGaD
